C Pioche1, B Salomon, D Klatzmann
1Laboratoire de Biologie et Thérapeutique des Pathologies Immunitaires, Hôpital de la Pitié, Paris, France.
Harnessing dendritic cells to present tumor antigens can enhance anti-tumor immune responses. Ex vivo-primed dendritic cells show promise for cancer immunotherapy by stimulating T cells.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science: